Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP)

  • Yoshihiko Sakata
  • , Go Saito
  • , Shinya Sakata
  • , Yuko Oya
  • , Motohiro Tamiya
  • , Hidekazu Suzuki
  • , Ryota Shibaki
  • , Asuka Okada
  • , Toshihide Yokoyama
  • , Hirotaka Matsumoto
  • , Taiichiro Otsuki
  • , Yuki Sato
  • , Uchida Junji
  • , Yoko Tsukita
  • , Megumi Inaba
  • , Hideki Ikeda
  • , Daisuke Arai
  • , Hirotaka Maruyama
  • , Satoshi Hara
  • , Shinsuke Tsumura
    • Jun Morinaga, Takuro Sakagami

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

8 被引用数 (Scopus)

フィンガープリント

「Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science